Picture of BioNeutra Global logo

BGA BioNeutra Global Income Statement

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapContrarian

Annual income statement for BioNeutra Global, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue32.137.737.724.115.4
Cost of Revenue
Gross Profit7.2410.40.6383.942.89
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses32.335.850.727.818.2
Operating Profit-0.191.95-13-3.68-2.83
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-1.083.57-13-3.77-2.83
Provision for Income Taxes
Net Income After Taxes-1.163.1-12.4-3.71-2.83
Net Income Before Extraordinary Items
Net Income-1.163.1-12.4-3.71-2.83
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-1.163.1-12.4-3.71-2.83
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.0310.065-0.244-0.074-0.061

Or unlock with your email

Or unlock with your email